ABCL Stock: Price, Earnings History and SEC Filings
AbCellera Biologics Inc. (ABCL) last traded at $12.27, down 6.19% on the latest session and down 15.9% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.18 against an analyst estimate of $-0.17, a miss of 5.9%.
$12.27 -6.19%
1 month-15.90%
52-week high$15.02
52-week low$2.75
Volume3.88M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ABCL earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $-0.18 | $-0.17 | -5.88% |
| Mar 2026 | May 11, 2026 | $-0.14 | $-0.22 | +36.36% |
| Dec 2025 | Feb 24, 2026 | $-0.03 | $-0.18 | +83.33% |
| Sep 2025 | Nov 6, 2025 | $-0.19 | $-0.17 | -11.76% |
ABCL beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
ABCL financial history
Revenue
Net income
Free cash flow
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $75M | -$146M | -$174M | -194.9% | $-0.49 |
| 2024 | $29M | -$163M | -$187M | -564.8% | $-0.55 |
| 2023 | $38M | -$146M | -$121M | -385.0% | $-0.51 |
| 2022 | $485M | $159M | $207M | 32.7% | $0.50 |
| 2021 | $375M | $153M | $186M | 40.9% | $0.48 |
| 2020 | $233M | $119M | $13M | 51.0% | $0.45 |
| 2019 | $12M | -$2M | -$1M | -19.0% | $-0.01 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for ABCL
SEC filing data is not available right now. You can search for ABCL on SEC EDGAR.
ABCL news
- AbCellera to Present at Upcoming Investor Conferences in November 2026Oct 22, 2026 · finance.yahoo.com
About AbCellera Biologics Inc.
AbCellera Biologics Inc. (ABCL) is a US-listed public company on Nasdaq.